Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'G-Protein Coupled Receptors (GPCRs) Market Report' returned 5 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom G-Protein Coupled Receptors (GPCRs) - Global Strategic Business Report   Global Industry Analysts, Inc., Feb 2011, Pages: 299 G-Protein Coupled Receptors (GPCRs) - Global Strategic Business Report This report analyzes the Global market for G-Protein Coupled Receptors (GPCRs) in US$ Billion. Annual estimates and forecasts GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing   GBI Research, Nov 2011, Pages: 143 commercial importance of G protein coupled receptors, which are the most important category of receptors in the human body. The report provides a scientific understanding of GPCRs and details the novel Proteomics - Technologies, Markets and Companies   Jain PharmaBiotech, June 2012, Pages: 616 targeting disease pathways Dynamic proteomics Identification of protein kinases as drug targets Mechanisms of action of kinase inhibitors G-protein coupled receptors as drug targets Methods of study of Diabetic Nephropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, April 2011, Pages: 72 , Nox4 inhibitor, G protein-coupled receptors (GPCRs) antagonist, and erythropoiesis stimulating agent. 1 Table of contents 1 Table of contents 1.1 List of Tables 1.2 List of Figures 2 Diabetic Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, April 2011, Pages: 84 inhibitors, TGF (transforming growth factor) inhibitors, lysophosphatidic acid (LPA), G-protein-coupled receptors (GPCRs) inhibitors, integrin receptor antagonist, ATPase-dependent hydrogen ion inhibitor Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network